ONWARD Medical Prepares for Financial Results Webcast
ONWARD Medical N.V. (Euronext: ONWD), a pioneering medical technology company focused on spinal cord stimulation therapies, has announced its plans to host a webcast detailing its Full Year 2024 Financial Results and latest business developments.
This highly anticipated event will take place on a date soon, with CEO Dave Marver leading the discussion to highlight key developments from 2024 and share insights into the company’s strategic direction.
Details of the Upcoming Webcast
The webcast is scheduled for early April, beginning at 2:00PM CET / 08:00AM ET. This presentation will cover various highlights and innovations from the year, allowing participants to gain a clearer understanding of ONWARD Medical’s advancements in technology and market presence.
How to Participate in the Webcast
To join this informative session, participants are encouraged to register beforehand. The registration process ensures efficient access to the webcast and preparatory materials.
Dial-in Options
For those preferring to participate by phone, ONWARD Medical provides several international dialing options. Attendees from different countries can call:
+32 2 290 9360 (Belgium)
+33 1 7095 0350 (France)
+49 69 3807 9884 (Germany)
+31 20 794 0854 (Netherlands)
+41 22 591 0156 (Switzerland)
+44 203 481 5240 (UK)
+1 346 248 7799 (US)
Conference ID for accessing the meeting is expected to be provided during registration.
Innovations at ONWARD Medical
ONWARD Medical is at the forefront of medical technology, dedicated to developing therapies that aim to restore movement, function, and independence for individuals with spinal cord injuries (SCI) and related disabilities. Through a robust framework of scientific inquiry, extensive preclinical research, and clinical trials, they have pioneered ARC Therapy.
This innovative therapy has gained the prestigious designation of Breakthrough Device by the US Food and Drug Administration (FDA) multiple times, illustrating the company’s commitment to pushing the boundaries of medical technology. Their latest product, the ARC-EX System, has received clearance for commercial use in the US, marking a significant achievement in real-world applications.
Future Developments and Focus Areas
Looking ahead, ONWARD Medical is also working on the ARC-IM system, both with and without brain-computer interface (BCI) capabilities. These investigational technologies promise to expand the capabilities of spinal cord therapies and serve as powerful tools in rehabilitation and recovery.
Company Background
Founded with the mission to improve the quality of life for individuals with movement disabilities, ONWARD Medical is headquartered in the Netherlands, with additional facilities in Switzerland and the US. Their dedication to research and development is what sets them apart in a competitive landscape of medical technology.
Connecting with ONWARD Medical
For those interested in staying updated on ONWARD Medical’s breakthroughs, research updates, and therapy openings, the company encourages subscribing to their newsletters. Educational resources are made available via their website, ensuring that stakeholders can access current and transformative information about their offerings.
Frequently Asked Questions
What is the purpose of the ONWARD Medical webcast?
The webcast aims to share the financial results for 2024 and highlight significant business developments and innovations in spinal cord therapy.
When will the webcast take place?
The webcast is set for early April, with a specific date to be announced soon.
Who will be presenting during the webcast?
CEO Dave Marver will host the livestream, presenting key insights and updates regarding ONWARD Medical's progress.
How can participants access the webcast?
Participants can register via the company’s website beforehand for efficient access to the event.
What should I know about ONWARD Medical?
ONWARD Medical specializes in spinal cord stimulation therapies, known for their innovative approach and commitment to improving the lives of individuals with movement disabilities.
